Industry urges more government action on antibiotic development

Publication

Center for Infectious Disease Research and Policy

By

Chris Dall

This article was published in CIDRAP 16 January 2020. A report by Chris Dall.

The level of funding for late-stage research and development of new antibiotics and other products to combat antimicrobial resistance (AMR) is insufficient to meet global health needs, and governments need to step up to the plate, according to an industry report released today.

More News

News

A Decade of Action on AMR: Reflections and Path to 2029

In the news

WAAW Webinar 2025

News

AMR Industry Alliance Releases “Principles for Pooled Procurement of AMR Products”